HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:
Guest Access | Sign In via User Name/Password

This Article Full Text Free Full Text (PDF) Free Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Article Archive Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (3) Citing Articles via Google Scholar Google Scholar Articles by van der Lee, I. Articles by van den Bosch, J. M.M. Search for Related Content PubMed PubMed Citation Articles by van der Lee, I. Articles by van den Bosch, J. M.M.

Diffusing Capacity for Nitric Oxide and Carbon Monoxide in Patients With Diffuse Parenchymal Lung Disease and Pulmonary Arterial Hypertension^*

^* From the Heart Lung Centre Utrecht, Department of Pulmonary Diseases, St. Antonius Hospital, Nieuwegein, the Netherlands.

Correspondence to: Ivo van der Lee, MD, Department of Pulmonary Diseases, Heart Lung Centre Utrecht, St. Antonius Hospital, PO Box 2500, 3430 EM Nieuwegein, the Netherlands; email: vdlee{at}tiscali.nl

Abstract

Background: The passage of carbon monoxide (CO) through the alveolocapillary membrane and into the plasma and intraerythrocytic compartments determines the diffusing capacity of the lung for CO (DLCO) as defined by the Roughton and Forster equation. On the other hand, the single-breath diffusing capacity of the lung for nitric oxide (DLNO) is thought to represent the true membrane diffusing capacity because of its very high affinity for hemoglobin (Hb) and its independence from pulmonary capillary blood volume. Therefore, the DLNO/DLCO ratio can be used to differentiate between thickened alveolocapillary membranes (both DLNO and DLCO are decreased, and the DLNO/DLCO ratio is normal) and decreased perfusion of ventilated alveoli (the DLNO less decreased than the DLCO; therefore, the DLNO/DLCO ratio is high) in patients with pulmonary disease.

Study design: We measured the combined values of DLCO and DLNO in 41 patients with diffuse parenchymal lung disease (DPLD), 26 patients with pulmonary arterial hypertension (PAH), and 71 healthy subjects.

Results: The DLCO (corrected to the standard Hb value) was lowered in the DPLD group (64% of predicted) and in the PAH group (64% of predicted), and was normal in the control group (105% of predicted). The DLNO/DLCO ratio in patients with PAH (4.98) was significantly higher than that in patients with DPLD (4.56) and in healthy subjects (4.36).

Conclusion: The DLNO/DLCO ratio is significantly higher in patients with PAH than in healthy subjects, although this ratio cannot be applied as a screening test to discriminate between patients with DPLD and PAH as the overlap between these groups is too large.

Key Words: interstitial lung disease • pulmonary diffusing capacity • pulmonary hypertension

This article has been cited by other articles:

				H. Dressel, L. Filser, R. Fischer, D. de la Motte, W. Steinhaeusser, R. M. Huber, D. Nowak, and R. A. Jorres Lung Diffusing Capacity for Nitric Oxide and Carbon Monoxide: Dependence on Breath-Hold Time Chest, May 1, 2008; 133(5): 1149 - 1154. [Abstract] [Full Text] [PDF]

				S. N. Glenet, C. De Bisschop, F. Vargas, and H. J. P. Guenard Deciphering the nitric oxide to carbon monoxide lung transfer ratio: physiological implications J. Physiol., July 15, 2007; 582(2): 767 - 775. [Abstract] [Full Text] [PDF]